Category
Discover how a virtual FDA mock inspection stress-tests your quality systems without disrupting active production schedules. As federal regulators expand Remote Regulatory Assessments (RRAs) under Section 704(a)(4), remote simulations allow…
Prepare your wellness brand for an FDA nutraceutical inspection under 21 CFR Part 111. While the commercial market uses the term nutraceutical, federal regulators evaluate these products strictly as dietary…
FDA’s Warning Letter to Novo Nordisk highlights growing FDA focus on pharmacovigilance, adverse event reporting, postmarket surveillance, and enterprise-wide quality systems beyond traditional GMP inspections.
Key Takeaways The FDA’s recent Warning Letter activity involving Novo Nordisk and semaglutide-related pharmacovigilance processes may represent another major signal that FDA inspections are evolving beyond traditional manufacturing floor oversight…
Sign in to access member resources, inspection tools and training.
New here? Create an account
Book a 60-minute strategy session with a former FDA investigator and decide your next step with confidence.
Book Consultation
